May 1
|
3 Profitable Stocks in the Doghouse
|
Apr 29
|
Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference
|
Apr 28
|
3 Reasons Growth Investors Will Love Penumbra (PEN)
|
Apr 28
|
Why Penumbra (PEN) is a Top Growth Stock for the Long-Term
|
Apr 26
|
Penumbra, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
|
Apr 25
|
Penumbra First Quarter 2025 Earnings: Beats Expectations
|
Apr 24
|
Penumbra Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Expand
|
Apr 24
|
Q1 2025 Penumbra Inc Earnings Call
|
Feb 14
|
Artivion (NYSE:AORT) Q3 Earnings: Leading The Medical Devices & Supplies - Cardiology, Neurology, Vascular Pack
|
Feb 14
|
Unpacking Q3 Earnings: ICU Medical (NASDAQ:ICUI) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
|
Feb 13
|
Spotting Winners: Penumbra (NYSE:PEN) And Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks In Q3
|
Feb 13
|
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Merit Medical Systems (NASDAQ:MMSI) Vs The Rest
|
Feb 12
|
Should You Add Penumbra Stock to Your Portfolio Right Now?
|
Dec 31
|
Capital Allocation Trends At Penumbra (NYSE:PEN) Aren't Ideal
|
Dec 30
|
Penumbra, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference
|
Dec 23
|
Here's Why Penumbra (PEN) is a Strong Growth Stock
|
Dec 20
|
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025
|
Dec 19
|
Penumbra price target raised to $285 from $240 at Truist
|